Results from in Vitro and Ex Vivo Skin Aging Models Assessing the Antiglycation and Anti-elastase MMP-12 Potential of Glycylglycine Oleamide

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2016 Jul 7

PMID 27382322

Citations 5

Authors

Patrick Bogdanowicz

Marie-Jose Haure

Isabelle Ceruti

Sandrine Bessou-Touya

Nathalie Castex-Rizzi

Affiliations

Soon will be listed here.

Abstract

Background: Glycation is an aging reaction of naturally occurring sugars with dermal proteins. Type I collagen and elastin are most affected by glycation during intrinsic chronological aging.

Aim: To study the in vitro and ex vivo assays in human skin cells and explants and the antiaging effects of glycylglycine oleamide (GGO).

Materials And Methods: The antiglycation effect of GGO was assessed in a noncellular in vitro study on collagen and, ex vivo, by immunohistochemical staining on human skin explants (elastin network glycation). The ability of GGO to contract fibroblasts was assessed in a functional assay, and its anti-elastase (MMP-12) activity was compared to that of oleic acid alone, glycylglycine (GG) alone, and oleic acid associated with GG.

Results: In vitro, GGO reduced the glycation of type I collagen. Ex vivo, GGO restored the expression of fibrillin-1 inhibited by glycation. Furthermore, GGO induced a tissue retraction of almost 30%. Moreover, the MMP-12 activity was inhibited by up to 60%.

Conclusion: Under the present in vitro and ex vivo conditions, GGO prevents glycation of the major structural proteins of the dermis, helping to reduce the risk of rigidification. By maintaining the elastic function of the skin, GGO may be a promising sparring partner for other topical antiaging agents.

Citing Articles

Fenugreek seed ethanolic extract inhibited formation of advanced glycation end products scavenging reactive carbonyl intermediates.

Anwar L, Ali S, Khan S, Uzairullah M, Mustafa N, Ali U Heliyon. 2023; 9(6):e16866.

PMID: 37484294 PMC: 10360956. DOI: 10.1016/j.heliyon.2023.e16866.

Tracing skin aging process: a mini- review of in vitro approaches.

Letsiou S Biogerontology. 2021; 22(3):261-272.

PMID: 33721158 DOI: 10.1007/s10522-021-09916-z.

In situ antioxidant activity of a dermo-cosmetic product: A randomized controlled clinical study.

Ribet V, Nobile V, Rossi A Exp Dermatol. 2019; 28(11):1219-1226.

PMID: 31309627 PMC: 6973136. DOI: 10.1111/exd.14005.

Novel Facial Cream Containing Carnosine Inhibits Formation of Advanced Glycation End-Products in Human Skin.

Narda M, Peno-Mazzarino L, Krutmann J, Trullas C, Granger C Skin Pharmacol Physiol. 2018; 31(6):324-331.

PMID: 30199874 PMC: 6262686. DOI: 10.1159/000492276.

A new dermocosmetic containing retinaldehyde, delta-tocopherol glucoside and glycylglycine oleamide for managing naturally aged skin: results from in vitro to clinical studies.

Rouvrais C, Bacqueville D, Bogdanowicz P, Haure M, Duprat L, Coutanceau C Clin Cosmet Investig Dermatol. 2017; 10:35-42.

PMID: 28203099 PMC: 5295789. DOI: 10.2147/CCID.S123575.

References

Detmar M . Molecular regulation of angiogenesis in the skin. J Invest Dermatol. 1996; 106(2):207-8. DOI: 10.1111/1523-1747.ep12340457. View

Farris P . Innovative cosmeceuticals: sirtuin activators and anti-glycation compounds. Semin Cutan Med Surg. 2011; 30(3):163-6. DOI: 10.1016/j.sder.2011.05.004. View

Kielty C, Woolley D, Whittaker S, Shuttleworth C . Catabolism of intact fibrillin microfibrils by neutrophil elastase, chymotrypsin and trypsin. FEBS Lett. 1994; 351(1):85-9. DOI: 10.1016/0014-5793(94)00818-3. View

Boldyrev A, Aldini G, Derave W . Physiology and pathophysiology of carnosine. Physiol Rev. 2013; 93(4):1803-45. DOI: 10.1152/physrev.00039.2012. View

Avery N, Bailey A . The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol Biol (Paris). 2006; 54(7):387-95. DOI: 10.1016/j.patbio.2006.07.005. View

Ashe B, Zimmerman M . Specific inhibition of human granulocyte elastase by cis-unsaturated fatty acids and activation by the corresponding alcohols. Biochem Biophys Res Commun. 1977; 75(1):194-9. DOI: 10.1016/0006-291x(77)91308-0. View

Gasser P, Arnold F, Peno-Mazzarino L, Bouzoud D, Luu M, Lati E . Glycation induction and antiglycation activity of skin care ingredients on living human skin explants. Int J Cosmet Sci. 2011; 33(4):366-70. DOI: 10.1111/j.1468-2494.2011.00640.x. View

Herman J, Rost-Roszkowska M, Skotnicka-Graca U . Skin care during the menopause period: noninvasive procedures of beauty studies. Postepy Dermatol Alergol. 2014; 30(6):388-95. PMC: 3907896. DOI: 10.5114/pdia.2013.39430. View

Sorrell J, Caplan A . Fibroblast heterogeneity: more than skin deep. J Cell Sci. 2004; 117(Pt 5):667-75. DOI: 10.1242/jcs.01005. View

10.

Choudhary M, Abbas G, Ali S, Shuja S, Khalid N, Khan K . Substituted benzenediol Schiff bases as promising new anti-glycation agents. J Enzyme Inhib Med Chem. 2010; 26(1):98-103. DOI: 10.3109/14756361003733621. View

11.

Chung J, Seo J, Choi H, Lee M, Youn C, Rhie G . Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol. 2001; 117(5):1218-24. DOI: 10.1046/j.0022-202x.2001.01544.x. View

12.

Naylor E, Watson R, Sherratt M . Molecular aspects of skin ageing. Maturitas. 2011; 69(3):249-56. DOI: 10.1016/j.maturitas.2011.04.011. View

13.

Pageon H, Techer M, Asselineau D . Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules. Exp Gerontol. 2008; 43(6):584-8. DOI: 10.1016/j.exger.2008.04.004. View

14.

DeGroot J . The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol. 2004; 4(3):301-5. DOI: 10.1016/j.coph.2004.01.007. View

15.

Pageon H . Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. Pathol Biol (Paris). 2009; 58(3):226-31. DOI: 10.1016/j.patbio.2009.09.009. View

16.

Kligman A . Early destructive effect of sunlight on human skin. JAMA. 1969; 210(13):2377-80. View

17.

Okano Y, Masaki H, Sakurai H . Dysfunction of dermal fibroblasts induced by advanced glycation end-products (AGEs) and the contribution of a nonspecific interaction with cell membrane and AGEs. J Dermatol Sci. 2002; 29(3):171-80. DOI: 10.1016/s0923-1811(02)00021-x. View

18.

Metcalfe A, Ferguson M . Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface. 2007; 4(14):413-37. PMC: 2373411. DOI: 10.1098/rsif.2006.0179. View

19.

Corstjens H, Dicanio D, Muizzuddin N, Neven A, Sparacio R, Declercq L . Glycation associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects. Exp Gerontol. 2008; 43(7):663-667. DOI: 10.1016/j.exger.2008.01.012. View

20.

Bell E, Ivarsson B, Merrill C . Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A. 1979; 76(3):1274-8. PMC: 383233. DOI: 10.1073/pnas.76.3.1274. View